PHARMACEUTICAL CAPSULE COMPOSITE FORMULATION CONTAINING TADALAFIL AND TAMSULOSIN Russian patent published in 2018 - IPC A61K31/4985 A61K31/18 A61K47/00 A61K9/16 A61K9/28 A61K9/48 A61P13/08 

Abstract RU 2672573 C2

FIELD: medicine.

SUBSTANCE: composite formulation of a capsule for preventing or treating erectile dysfunction and benign prostatic hyperplasia containing an independent portion comprising a tadalafil and an independent portion comprising tamsulosin in a separate state and a method for its production. Said independent part of tadalafil is in the form of tablets. Said independent part of tamsulosin is in the form of granules. Said independent part of the tadalafil is coated with a pharmaceutically acceptable coating material. Said independent part of tamsulosin is coated with an inner coating material, which is a mixture of povidone, propylene glycol and polyvinyl acetate, and then coated with an outer coating material, which is a mixture of a methacrylate-ethyl acrylate copolymer and a triacetin.

EFFECT: composite formulation of the capsule of the present invention provides for the complete separation of the two pharmaceutically active ingredients and minimizes the reactivity between the active ingredients and thus provides a satisfactory product stability over time, thereby maximizing its therapeutic effects.

7 cl, 7 dwg, 6 tbl, 3 ex

Similar patents RU2672573C2

Title Year Author Number
USE OF COMPOSITION FOR NON-HORMONAL CONTRACEPTION AND PACKAGING 2019
  • El Glaoui, Guillaume
  • El Glaoui, Mehdi
  • Perrin, Philippe
  • Droupy, Stephane
  • Agathon-Meriau, Veronique
RU2799756C2
COMPOSITE PREPARATION COMPRISING FILM COATING LAYER CONTAINING ACTIVE INGREDIENT 2015
  • Kim Hyung Seo
  • Cho Jung Hyun
  • Choi Young Keun
  • Kim Kyeong Soo
  • Kim Jin Cheul
  • Kim Yong Il
  • Park Jae Hyun
  • Woo Jong Soo
RU2696563C2
LONG-ACTING CONTROLLED-RELEASE SUBCUTANEOUS POLYMER IMPLANT OF PHARMACOLOGICAL PRE-CONCENTRATED SUBSTANCE FOR TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA 2020
  • Luiz Perakki Edson
RU2822514C1
PDE INHIBITORS AND THEIR COMBINATIONS FOR TREATMENT OF UROLOGIC DISORDERS 2006
  • Ul'Brikh Ehrnst
  • Zandner Peter
  • Tinel' Khanna
  • Khjutter Joakhim
RU2435588C2
MEDICINE CONTAINING SODIUM PENTOZANPOLISULPHATE FOR USE IN THE TREATMENT OF THE OBSTRUCTION OF THE BLADDER AND/OR SYMPTOMS OF THE LOWER URINARY TRACT 2016
  • Swati Vishal Jajodia
RU2680098C1
PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE ACTIVE SUBSTANCE 2004
  • Kukhar Polontsa
  • Sirtsa Judita
RU2447884C2
METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA 2019
  • Bespalov Vladimir Grigorevich
  • Lukin Dmitrij Evgenevich
RU2764850C1
PHARMACEUTICAL PREPARATION FOR TREATING BENIGN PROSTATIC HYPERPLASIA 2008
  • Desser Ljuchija
  • Lotts Bernkhard
  • Mor Tomas
RU2485971C2
PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES 2012
  • Shvarts Gennadij Jakovlevich
  • Shvarts Pavel Gennadievich
RU2497504C1
MEDICATION FOR TREATING GENITOURINARY SYSTEM DISEASES AND METHOD OF TREATING GENITOURINARY SYSTEM DISEASES 2011
  • Ehpshtejn Oleg Il'Ich
RU2565400C2

RU 2 672 573 C2

Authors

Park Kaleb Khiungmin

Kim Jong Il

Park Dzae Khiun

Voo Dzong Soo

Joon Joung-Su

Dates

2018-11-16Published

2014-06-30Filed